Cancer Prevention Center
CENTER FOR CANCER PREVENTION AT STONY BROOK
In 2006 Stony Brook University established the Center for Cancer Prevention at Stony Brook, directed by Dr. B. Rigas. Endorsed by Deans R. Fine and Y. Shamash, it represents a joint effort of the School of Medicine and the College of Engineering and Applied Sciences, respectively. The Center has already received federal funding for its program on “Cancer Prevention Though Wireless Sensing.”
Mission of the Center
To develop in a timely manner effective and widely applicable methods to prevent human cancer by recruiting to and integrating into the process of discovery emerging novel disciplines and rapidly evaluating preclinical findings in humans.
The Center will embody a structured approach that will cover the entire spectrum from the earliest basic knowledge all the way to its final translational component. Initially, work will focus on the integration into cancer prevention of novel sensors and (micro)imaging modalities for the early detection of cancer based on chemical and other structural changes of the cancer cell; on the delineation of relevant pathways and interactions with novel drugs; and on the validation of preclinical findings through clinical trials conducted in our hospital.
Basil Rigas, M.D., D.Sc., Professor of Medicine and Professor of Pharmacological Sciences, is the Director of the Center. His work focuses on cancer prevention using novel approaches and ranges from the development of new agents to their preclinical and clinical assessment.
Shmuel Einav, Ph.D. is a Professor and Associate Dean in the College of Engineering and Applied Sciences. Dr. Einav has extensive experience in engineering system integration; in engineering design, data analysis, management and statistical analysis; and in the design and characterization of wireless sensors.
Michael Frohman, M.D., Ph.D., is a Professor of Pharmacology and the Director of the Medical Scientist Training Program. Dr. Frohman has long-standing expertise in molecular biology and has developed the “RACE-PCR” methodology. More recently, his research interests have centered on signal transduction mediated by lipid second messengers, on which he holds several patents for the cloning of a superfamily of signaling genes. Dr. Frohman’s research focuses, in part, on signaling in breast, prostate, and pancreatic cancer and the response to oxidative damage.
Miriam Rafailovich, Ph.D., is a Professor of Materials Science and Chemical Engineering in the College of Engineering and Applied Sciences. Dr. Rafailovich is an expert in polymer surfaces and interfaces and is developing nanocomposite materials for biological sensing and tissue engineering. She directs the Garcia Materials Research Science and Engineering Center at Sony Brook.